Humacyte Inc Warrant
HUMAW
8 hedge funds and large institutions have $4.38K invested in Humacyte Inc Warrant in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
91% less capital invested
Capital invested by funds: $46.1K → $4.38K (-$41.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$681 |
| 2 |
CS
Clear Street
New York
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.24K |
| 2 |
LPL Financial
San Diego,
California
|
-$1.63K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$7 |
HUMAW Hedge Fund Activity: Q2 2026 in Review
8 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q2 2026, worth a combined $4.38K — down 91% from $46.1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new HUMAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $681. The largest seller was Susquehanna International Group, cutting an estimated $2.24K.
- 8 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q2 2026, up from 7 in Q1 2026.
- Funds reported $4.38K of Humacyte Inc Warrant stock for Q2 2026, down 91% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q2 2026 and 0 closed out, a net change of +1 holder.
- The largest Humacyte Inc Warrant buyer in Q2 2026 was Wolverine Asset Management, an estimated $681 added.
- The largest Humacyte Inc Warrant seller in Q2 2026 was Susquehanna International Group, an estimated $2.24K sold.
Based on aggregated 13F filings for Q2 2026.